Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - GROSS PROFIT
Gross Profit ITCI - Intra-Cellular Therapies, Inc.
431 M
LAST VALUE
141.77%
2 YEAR CAGR
310.81%
5 YEAR CAGR
36.96%
10 YEAR CAGR